Stock Market Reviews

GRFS (Grifols, S.A.) News

Get the latest news, insights, and market updates on GRFS (Grifols, S.A.). Explore the news page 1 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.

• European Equities Traded in the US as American Depositary Receipts Decline in Friday Trading
  European equities traded in the US as American depositary receipts were tracking lower late Friday m
  Nov 14, 2025 - $GRFS
• European Equities Traded in the US as American Depositary Receipts Slightly Higher in Thursday Trading
  European equities traded in the US as American depositary receipts were slightly higher late Thursda
  Nov 13, 2025 - $GRFS
• How Might Currency Pressures and Regulatory Delays Shape Grifols' (BME:GRF) Growth Prospects?
  Grifols S.A. recently reported its Q3 2025 results, with adjusted earnings of €0.21 per share and revenue rising 4% to €1.87 billion, slightly surpassing analyst expectations. Despite exceeding forecasts, the company faced concern over currency headwinds and delays in FDA approval for its fibrinogen treatment, highlighting operational challenges alongside its growth. We will explore how concerns over foreign exchange impacts and regulatory delays may affect Grifols' underlying investment...
  Nov 8, 2025 - $GRFS
• Down 10.4% in 4 Weeks, Here's Why Grifols (GRFS) Looks Ripe for a Turnaround
  Grifols (GRFS) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
  Nov 6, 2025 - $GRFS
• European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading
  European equities traded in the US as American depositary receipts were lower late Thursday morning,
  Nov 6, 2025 - $GRFS
• Grifols SA (GRFS) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Improved ...
  Grifols SA (GRFS) reports robust year-over-year growth with significant improvements in revenue, EBITDA, and free cash flow, despite facing exchange rate and pricing challenges.
  Nov 5, 2025 - $GRFS
• European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading
  European equities traded in the US as American depositary receipts were tracking higher late Wednesd
  Nov 5, 2025 - $GRFS
• Is Grifols (GRFS) Stock Outpacing Its Medical Peers This Year?
  Here is how Grifols (GRFS) and Arcutis Biotherapeutics, Inc. (ARQT) have performed compared to their sector so far this year.
  Oct 30, 2025 - $GRFS
• GRFS vs. ZTS: Which Stock Is the Better Value Option?
  GRFS vs. ZTS: Which Stock Is the Better Value Option?
  Oct 27, 2025 - $GRFS
• Are Investors Undervaluing Grifols (GRFS) Right Now?
  Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
  Oct 27, 2025 - $GRFS